Tag: drug discovery

  • Slashdot: Microsoft Says AI Can Create ‘Zero Day’ Threats In Biology

    Source URL: https://science.slashdot.org/story/25/10/02/2335217/microsoft-says-ai-can-create-zero-day-threats-in-biology?utm_source=rss1.0mainlinkanon&utm_medium=feed Source: Slashdot Title: Microsoft Says AI Can Create ‘Zero Day’ Threats In Biology Feedly Summary: AI Summary and Description: Yes Summary: Microsoft’s team has identified a significant vulnerability in biosecurity systems using AI, highlighting the dual-use capabilities of generative AI in potentially enabling bioweapons development. This discovery emphasizes the urgent need for…

  • Cloud Blog: How Google Cloud’s AI tech stack powers today’s startups

    Source URL: https://cloud.google.com/blog/topics/startups/differentiated-ai-tech-stack-drives-startup-innovation-google-builders-forum/ Source: Cloud Blog Title: How Google Cloud’s AI tech stack powers today’s startups Feedly Summary: AI has accelerated startup innovation more than any technology since perhaps the internet itself, and we’ve been fortunate to have a front row seat to much of this innovation here at Google Cloud. Nine of the top…

  • Cloud Blog: Google Public Sector supports AI-optimized HPC infrastructure for researchers at Caltech

    Source URL: https://cloud.google.com/blog/topics/public-sector/google-public-sector-supports-ai-optimized-hpc-infrastructure-for-researchers-at-caltech/ Source: Cloud Blog Title: Google Public Sector supports AI-optimized HPC infrastructure for researchers at Caltech Feedly Summary: For decades, institutions like Caltech, have been at the forefront of large-scale artificial intelligence (AI) research. As high-performance computing (HPC) clusters continue to evolve, researchers across disciplines have been increasingly equipped to process massive datasets,…

  • Slashdot: Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs

    Source URL: https://science.slashdot.org/story/25/07/06/2124226/google-deepminds-spinoff-company-very-close-to-human-trials-for-its-ai-designed-drugs Source: Slashdot Title: Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs Feedly Summary: AI Summary and Description: Yes Summary: The text illustrates the significant advancements in AI-driven drug discovery, particularly highlighting Isomorphic Labs’ plans to initiate human clinical trials using AI-designed drugs. This aligns closely with the…

  • OpenAI : Preparing for future AI risks in biology

    Source URL: https://openai.com/index/preparing-for-future-ai-capabilities-in-biology Source: OpenAI Title: Preparing for future AI risks in biology Feedly Summary: Advanced AI can transform biology and medicine—but also raises biosecurity risks. We’re proactively assessing capabilities and implementing safeguards to prevent misuse. AI Summary and Description: Yes Summary: The text emphasizes the transformative potential of advanced AI in biology and medicine…

  • AWS News Blog: New Amazon EC2 P6-B200 instances powered by NVIDIA Blackwell GPUs to accelerate AI innovations

    Source URL: https://aws.amazon.com/blogs/aws/new-amazon-ec2-p6-b200-instances-powered-by-nvidia-blackwell-gpus-to-accelerate-ai-innovations/ Source: AWS News Blog Title: New Amazon EC2 P6-B200 instances powered by NVIDIA Blackwell GPUs to accelerate AI innovations Feedly Summary: The P6-B200 EC2 instances powered by NVIDIA Blackwell B200 GPUs offer up to twice the performance of previous P5en instances for machine learning and high-performance computing workloads. AI Summary and Description:…

  • Cloud Blog: SandboxAQ: Accelerating drug discovery through cloud integration

    Source URL: https://cloud.google.com/blog/products/infrastructure-modernization/sandboxaq-speeds-up-drug-discovery-with-the-cloud/ Source: Cloud Blog Title: SandboxAQ: Accelerating drug discovery through cloud integration Feedly Summary: The traditional drug discovery process involves massive capital investments, prolonged timelines, and is plagued with daunting failure rates. From initial research to obtaining regulatory approval, bringing a new drug to market can take decades. During this time, many drug…